1. Home
  2. VSTS vs NNNN Comparison

VSTS vs NNNN Comparison

Compare VSTS & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$11.99

Market Cap

1.0B

Sector

N/A

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$25.50

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTS
NNNN
Founded
1936
2021
Country
United States
Germany
Employees
N/A
27
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
VSTS
NNNN
Price
$11.99
$25.50
Analyst Decision
Sell
Analyst Count
4
0
Target Price
$5.88
N/A
AVG Volume (30 Days)
1.0M
12.0K
Earning Date
05-12-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,734,839,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.67
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$3.98
$7.03
52 Week High
$10.38
$55.65

Technical Indicators

Market Signals
Indicator
VSTS
NNNN
Relative Strength Index (RSI) 78.26 41.34
Support Level $7.24 $19.53
Resistance Level N/A $30.21
Average True Range (ATR) 0.43 2.22
MACD 0.06 -0.48
Stochastic Oscillator 86.40 20.40

Price Performance

Historical Comparison
VSTS
NNNN

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: